ctrl K

Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.77

0.03 (4.41%)

At close: Aug 15, 2025, 3:54 PM

0.76

-1.28%

After-hours: Aug 15, 2025, 04:07 PM EDT

Virax Biolabs Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	6.33K	156.42K	8.56K	n/a	123.82K
Cost of Revenue	59.4K	105.83K	9.93K	n/a	133.25K
Gross Profit	-53.07K	50.59K	-1.36K	n/a	-9.43K
Operating Income	-6.16M	-6.5M	-5.73M	-1.73M	-644.54K
Interest Income	n/a	n/a	n/a	15.44K	n/a
Pretax Income	-6.2M	-6.74M	-5.46M	-1.75M	-672.91K
Net Income	-6.06M	-6.73M	-5.46M	-1.71M	-650.98K
Selling & General & Admin	4.33M	4.59M	5.33M	1.3M	514.88K
Research & Development	1.78M	1.56M	397.11K	433.74K	120.22K
Other Expenses	n/a	390.36K	n/a	n/a	266.00
Operating Expenses	6.11M	6.55M	5.73M	1.73M	635.1K
Interest Expense	58.18K	26.88K	15.47K	15.44K	28.64K
Selling & Marketing Expenses	n/a	n/a	26.62K	13.82K	57.2K
Cost & Expenses	6.17M	6.65M	5.74M	1.73M	768.36K
Income Tax Expense	-136.66K	n/a	-271	n/a	n/a
Shares Outstanding (Basic)	3.1M	2.01M	1.06M	1.14M	1.14M
Shares Outstanding (Diluted)	3.1M	2.01M	1.06M	1.14M	1.14M
EPS (Basic)	-1.96	-3.36	-5.13	-1.5	-0.57
EPS (Diluted)	-1.95	-3.36	-5.13	-1.5	-0.57
EBITDA	-5.8M	-6.61M	-5.44M	-750	n/a
EBIT	-6.15M	-6.71M	-5.44M	-1.73M	-644.27K
Depreciation & Amortization	343.39K	103.1K	n/a	1.73M	644.54K